BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22281432)

  • 21. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
    Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in CYP1A1, CYP2D6, UGT1A6, UGT1A7, and SULT1A1 genes and correlation with benzene exposure in a Chinese occupational population.
    Gu SY; Zhang ZB; Wan JX; Jin XP; Xia ZL
    J Toxicol Environ Health A; 2007 Jun; 70(11):916-24. PubMed ID: 17479406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
    Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
    Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of CYP1A1 gene polymorphism with chronic kidney disease: a case control study.
    Siddarth M; Datta SK; Ahmed RS; Banerjee BD; Kalra OP; Tripathi AK
    Environ Toxicol Pharmacol; 2013 Jul; 36(1):164-70. PubMed ID: 23619522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population.
    Pandey SN; Choudhuri G; Mittal B
    Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
    Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer.
    Smits KM; Schouten LJ; van Dijk BA; van Houwelingen K; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Oosterwijk E; van den Brandt PA
    World J Urol; 2008 Feb; 26(1):103-10. PubMed ID: 17982751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia.
    Idris HME; Khalil HB; Mills J; Elderdery AY
    Curr Cancer Drug Targets; 2020; 20(9):675-680. PubMed ID: 32418524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
    Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
    Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
    Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitis.
    Kim JS; Park JY; Chung WY; Choi MA; Cho KS; Park KK
    J Clin Periodontol; 2004 Nov; 31(11):959-64. PubMed ID: 15491310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.
    Malik MA; Upadhyay R; Mittal RD; Zargar SA; Mittal B
    Nutr Cancer; 2010; 62(6):734-42. PubMed ID: 20661821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
    Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
    Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population.
    Losi-Guembarovski R; Cólus IM; De Menezes RP; Poliseli F; Chaves VN; Kuasne H; Leichsenring A; Guembarovski AL; Oliveira BW; Ramos G; Cavalcanti TC; Mizuno LT; Cavalli IJ; Ribeiro EM
    Anticancer Res; 2008; 28(2A):1023-8. PubMed ID: 18507050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population.
    Nakamura E; Megumi Y; Kobayashi T; Kamoto T; Ishitoya S; Terachi T; Tachibana M; Matsushiro H; Habuchi T; Kakehi Y; Ogawa O
    Clin Cancer Res; 2002 Aug; 8(8):2620-5. PubMed ID: 12171893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of xenobiotic-metabolizing enzyme genotypes PON1Q192R, PON1L55M and CYP1A1*2A MspI with pathological symptoms of a rural population in south Greece.
    Tsatsakis AM; Androutsopoulos VP; Zafiropoulos A; Babatsikou F; Alegakis T; Dialyna I; Tzatzarakis M; Koutis C
    Xenobiotica; 2011 Oct; 41(10):914-25. PubMed ID: 21718208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
    Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
    Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.